[Pharmacotherapy of tobacco smoking from the point of view of the clinical cardiologist].
Medical programs supporting smoking cessation are a complex task to set up. Each smoker should be evaluated for his stage of motivation to change, his nicotine dependence degree and also for the presence of relevant existing comorbidities. Several non pharmacologic techniques and a number of drugs have been demonstrated clearly effective in the smoking cessation therapy field. The purpose of this review is to analyse the available drug therapies mainly considering their possible use in the clinical cardiology "real world" scenario. Specific attention has been paid to the cardiovascular safety of each drug therapy trying to anticipate possible questions and concerns emerging in the daily practice of the clinical cardiologist, who normally can't be considered a smoking cessation "natural born" specialist.